Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension Article

Shi, Yinan, Gu, Chenxin, Zhao, Tongtong et al. (2021). Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension . Frontiers in Pharmacology, 12 10.3389/fphar.2021.758763

Open Access International Collaboration

cited authors

  • Shi, Yinan; Gu, Chenxin; Zhao, Tongtong; Jia, Yangfan; Bao, Changlei; Luo, Ang; Guo, Qiang; Han, Ying; Wang, Jian; Black, Stephen M; Desai, Ankit A; Tang, Haiyang

sustainable development goals

authors

publication date

  • November 11, 2021

published in

keywords

  • ACTIVATION
  • ARTERIAL-HYPERTENSION
  • EXPRESSION
  • GROWTH
  • Life Sciences & Biomedicine
  • MECHANISMS
  • MTOR signaling
  • MTORC2
  • PAH
  • PASMCs
  • PATHOGENIC ROLE
  • PDGFRs
  • PROLIFERATION
  • Pharmacology & Pharmacy
  • Science & Technology
  • imatinib
  • rapamycin

Digital Object Identifier (DOI)

volume

  • 12